Examine the data and tweets to deduce if the closing price of $amgn will boost or lower at 2017-03-17. Kindly confirm either Rise or Fall.
Context: date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2017-03-03,-1.0,0.2,-1.5,1.2,1.2,-1.3,-2.5,-3.7,-4.7,-6.4,-7.9
2017-03-06,0.1,0.5,-0.7,-0.4,-0.4,-0.5,-1.8,-2.8,-4.0,-5.5,-7.1
2017-03-07,0.0,0.7,-0.6,-1.2,-1.2,0.7,-0.4,-1.3,-2.5,-3.9,-5.5
2017-03-08,-0.3,0.6,-0.4,0.2,0.2,0.4,-0.3,-1.2,-2.4,-3.6,-5.2
2017-03-09,-0.5,0.1,-1.0,0.6,0.6,-0.1,-0.7,-1.5,-2.7,-3.7,-5.3
2017-03-10,-1.1,0.3,-1.3,1.4,1.4,-1.3,-1.7,-2.6,-3.6,-4.6,-6.1
2017-03-13,0.5,0.5,-0.4,-0.2,-0.2,-1.0,-1.2,-2.1,-3.0,-4.0,-5.4
2017-03-14,0.2,0.8,-0.3,-0.5,-0.5,-0.1,-0.5,-1.3,-2.2,-3.2,-4.5
2017-03-15,-1.3,0.9,-1.3,1.4,1.4,-1.0,-1.6,-2.3,-3.1,-4.2,-5.3
2017-03-16,0.8,1.0,-1.2,-1.4,-1.4,0.5,-0.1,-0.7,-1.5,-2.5,-3.6

2017-03-03: rt AT_USER $auph will have promotional opportunities at the national kidney foundation meeting (april 18-22) : there will be $amgn $a¡­|rt AT_USER success with bispecific mab enabling tcell propinquit
2017-03-04: a revealing look at the 4 horsemen of biotech through a free cash flow lens  $celg $amgn $biib $gild|rt AT_USER in the history of great pharma m&amp;a values, when abbott picked up the basf pharma bus
2017-03-05: $amgn max pain is 167.50 for maturity 03/10/2017. prev close = 180.20.   |this writer is a liar! they did not say that! $agn myl $mrk $jnj $amgn $bmy $teva $ipxl $fb $prgo $nvs $sny $lly |rt AT_USER s
2017-03-06: rt AT_USER $adxs announces fda acceptance of ind for adxs-neo being developed in collaboration with $amgn|lookalike-drug maker to #amgen: we don't need your 'trade secrets'. read more:  $amgn|$amgn su
2017-03-07: rt AT_USER 'AT_USER gives 3 names to buy in health care $xlv $amgn $mrk $hum |trump tweets about a "new system" to lower dr... $pjp $ihe $xph $pph $gild $biib $amgn $shpg $prgo $myl $vrx |amgen declar
2017-03-08: $amgn rolls out new repatha ad |amgen, inc. $amgn plans $1.15 quarterly dividend |#amreading amgen (amgn) presents at cowen and company 37th annual health care conference - slideshow $amgn |amgen (amg
2017-03-09: rt AT_USER $spx #52weekhighs drop w/the market this week. $xlv getting healthier. #topdownthermometer #investools #ripbig #trendtr¡­|rt AT_USER $spx #52weekhighs drop w/the market this week. $xlv gett
2017-03-10: $amgn new trend line about 185 atm|$amgn futher rise in the trend is signaled could see 200-210+ in 90 days support AT_USER 177 175|why valeant $vrx $agn $myl $mrk $jnj $snap $twtr $fb $aapl $iep $gil
2017-03-11: rt AT_USER $spx #52weekhighs drop w/the market this week. $xlv getting healthier. #topdownthermometer #investools #ripbig #trendtr¡­|rt AT_USER $amgn $espr $mdco repatha outcome data next friday,  &gt
2017-03-12: benzinga: your guide to patent play exposure  $aapl $amgn $regn $sny $bbry $qcom $prkr $rpxc $spex $nok $tasr $dgly|your guide to patent play exposure  $aapl $amgn $regn $sny $bbry $qcom $prkr $rpxc $
2017-03-13: $amgn:us rpt-data on heart benefits of amgen drug is key to unlocking sales #amgen inc   #nasdaq|$amgn:us rpt-data on heart benefits of amgen drug is key to unlocking sales #amgen inc   #sp500|looking
2017-03-14: $amgn steers #pcsk9 blockbuster hopeful through another promising phiii, but the critical test is looming  $sny|$amgn: analyst action by ubs on amgen: |$amgn max pain is 175.00 for maturity 03/17/2017
2017-03-15: rt AT_USER ahead of the #acc17 fourier presentation, here's an interview i did w/harvard pilgrim on repatha risk sharing. |$amgn:us mizuho analysts give amgen, inc. (amgn) a $195.00 price target #amge
2017-03-16: AT_USER $amgn news is on their cholesterol drug, re: cv benefits|rt AT_USER nice job rbc surveying 100 cardiologist on cholesterol lowering drugs   10 key takeaways $amgn $regn $mrk $espr $mdco |get t
Answer:
Examine the data and tweets to deduce if the closing price of $amgn will boost or lower at 2017-03-17. Kindly confirm either Rise or Fall.
Context: date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2017-03-03,-1.0,0.2,-1.5,1.2,1.2,-1.3,-2.5,-3.7,-4.7,-6.4,-7.9
2017-03-06,0.1,0.5,-0.7,-0.4,-0.4,-0.5,-1.8,-2.8,-4.0,-5.5,-7.1
2017-03-07,0.0,0.7,-0.6,-1.2,-1.2,0.7,-0.4,-1.3,-2.5,-3.9,-5.5
2017-03-08,-0.3,0.6,-0.4,0.2,0.2,0.4,-0.3,-1.2,-2.4,-3.6,-5.2
2017-03-09,-0.5,0.1,-1.0,0.6,0.6,-0.1,-0.7,-1.5,-2.7,-3.7,-5.3
2017-03-10,-1.1,0.3,-1.3,1.4,1.4,-1.3,-1.7,-2.6,-3.6,-4.6,-6.1
2017-03-13,0.5,0.5,-0.4,-0.2,-0.2,-1.0,-1.2,-2.1,-3.0,-4.0,-5.4
2017-03-14,0.2,0.8,-0.3,-0.5,-0.5,-0.1,-0.5,-1.3,-2.2,-3.2,-4.5
2017-03-15,-1.3,0.9,-1.3,1.4,1.4,-1.0,-1.6,-2.3,-3.1,-4.2,-5.3
2017-03-16,0.8,1.0,-1.2,-1.4,-1.4,0.5,-0.1,-0.7,-1.5,-2.5,-3.6

2017-03-03: rt AT_USER $auph will have promotional opportunities at the national kidney foundation meeting (april 18-22) : there will be $amgn $a¡­|rt AT_USER success with bispecific mab enabling tcell propinquit
2017-03-04: a revealing look at the 4 horsemen of biotech through a free cash flow lens  $celg $amgn $biib $gild|rt AT_USER in the history of great pharma m&amp;a values, when abbott picked up the basf pharma bus
2017-03-05: $amgn max pain is 167.50 for maturity 03/10/2017. prev close = 180.20.   |this writer is a liar! they did not say that! $agn myl $mrk $jnj $amgn $bmy $teva $ipxl $fb $prgo $nvs $sny $lly |rt AT_USER s
2017-03-06: rt AT_USER $adxs announces fda acceptance of ind for adxs-neo being developed in collaboration with $amgn|lookalike-drug maker to #amgen: we don't need your 'trade secrets'. read more:  $amgn|$amgn su
2017-03-07: rt AT_USER 'AT_USER gives 3 names to buy in health care $xlv $amgn $mrk $hum |trump tweets about a "new system" to lower dr... $pjp $ihe $xph $pph $gild $biib $amgn $shpg $prgo $myl $vrx |amgen declar
2017-03-08: $amgn rolls out new repatha ad |amgen, inc. $amgn plans $1.15 quarterly dividend |#amreading amgen (amgn) presents at cowen and company 37th annual health care conference - slideshow $amgn |amgen (amg
2017-03-09: rt AT_USER $spx #52weekhighs drop w/the market this week. $xlv getting healthier. #topdownthermometer #investools #ripbig #trendtr¡­|rt AT_USER $spx #52weekhighs drop w/the market this week. $xlv gett
2017-03-10: $amgn new trend line about 185 atm|$amgn futher rise in the trend is signaled could see 200-210+ in 90 days support AT_USER 177 175|why valeant $vrx $agn $myl $mrk $jnj $snap $twtr $fb $aapl $iep $gil
2017-03-11: rt AT_USER $spx #52weekhighs drop w/the market this week. $xlv getting healthier. #topdownthermometer #investools #ripbig #trendtr¡­|rt AT_USER $amgn $espr $mdco repatha outcome data next friday,  &gt
2017-03-12: benzinga: your guide to patent play exposure  $aapl $amgn $regn $sny $bbry $qcom $prkr $rpxc $spex $nok $tasr $dgly|your guide to patent play exposure  $aapl $amgn $regn $sny $bbry $qcom $prkr $rpxc $
2017-03-13: $amgn:us rpt-data on heart benefits of amgen drug is key to unlocking sales #amgen inc   #nasdaq|$amgn:us rpt-data on heart benefits of amgen drug is key to unlocking sales #amgen inc   #sp500|looking
2017-03-14: $amgn steers #pcsk9 blockbuster hopeful through another promising phiii, but the critical test is looming  $sny|$amgn: analyst action by ubs on amgen: |$amgn max pain is 175.00 for maturity 03/17/2017
2017-03-15: rt AT_USER ahead of the #acc17 fourier presentation, here's an interview i did w/harvard pilgrim on repatha risk sharing. |$amgn:us mizuho analysts give amgen, inc. (amgn) a $195.00 price target #amge
2017-03-16: AT_USER $amgn news is on their cholesterol drug, re: cv benefits|rt AT_USER nice job rbc surveying 100 cardiologist on cholesterol lowering drugs   10 key takeaways $amgn $regn $mrk $espr $mdco |get t
Answer:+Fall